» Articles » PMID: 10848595

Evidence for an Interaction Between Ubiquitin-conjugating Enzymes and the 26S Proteasome

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 2000 Jun 10
PMID 10848595
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

The targeting of proteolytic substrates is accomplished by a family of ubiquitin-conjugating (E2) enzymes and a diverse set of substrate recognition (E3) factors. The ligation of a multiubiquitin chain to a substrate can promote its degradation by the proteasome. However, the mechanism that facilitates the translocation of a substrate to the proteasome in vivo is poorly understood. We have discovered that E2 proteins, including Ubc1, Ubc2, Ubc4, and Ubc5, can interact with the 26S proteasome. Significantly, the interaction between Ubc4 and the proteasome is strongly induced by heat stress, consistent with the requirement for this E2 for efficient stress tolerance. A catalytically inactive derivative of Ubc4 (Ubc4(C86A)), which causes toxicity in yeast cells, can also bind the proteasome. Purified proteasomes can ligate ubiquitin to a test substrate without the addition of exogenous E2 protein, suggesting that the ubiquitylation of some proteolytic substrates might be directly coupled to degradation by the proteasome.

Citing Articles

The ubiquitin-conjugating enzyme UBE2D maintains a youthful proteome and ensures protein quality control during aging by sustaining proteasome activity.

Hunt L, Curley M, Nyamkondiwa K, Stephan A, Jiao J, Kavdia K PLoS Biol. 2025; 23(1):e3002998.

PMID: 39879147 PMC: 11778781. DOI: 10.1371/journal.pbio.3002998.


Modulation of Inflammatory Response by Electromagnetic Field Stimulation in Traumatic Brain Injury in Yucatan Swine.

Mendoza-Mari Y, Rai V, Radwan M, Brazdzionis J, Connett D, Miulli D J Surg Res (Houst). 2024; 7(1):20-40.

PMID: 38389906 PMC: 10883333. DOI: 10.26502/jsr.10020338.


Predicting Clinical Outcomes 7-10 Years after Severe Traumatic Brain Injury: Exploring the Prognostic Utility of the IMPACT Lab Model and Cerebrospinal Fluid UCH-L1 and MAP-2.

Svingos A, Robicsek S, Hayes R, Wang K, Robertson C, Brophy G Neurocrit Care. 2022; 37(1):172-183.

PMID: 35229233 DOI: 10.1007/s12028-022-01461-y.


Serum biomarkers in severe paediatric traumatic brain injury-a narrative review.

Ganeshalingham A, Beca J Transl Pediatr. 2021; 10(10):2720-2737.

PMID: 34765496 PMC: 8578762. DOI: 10.21037/tp-20-386.


Altered levels of plasma neuron-derived exosomes and their cargo proteins characterize acute and chronic mild traumatic brain injury.

Goetzl E, Elahi F, Mustapic M, Kapogiannis D, Pryhoda M, Gilmore A FASEB J. 2019; 33(4):5082-5088.

PMID: 30605353 PMC: 6436652. DOI: 10.1096/fj.201802319R.


References
1.
Seufert W, Jentsch S . Ubiquitin-conjugating enzymes UBC4 and UBC5 mediate selective degradation of short-lived and abnormal proteins. EMBO J. 1990; 9(2):543-50. PMC: 551698. DOI: 10.1002/j.1460-2075.1990.tb08141.x. View

2.
Tongaonkar P, Beck K, Shinde U, Madura K . Characterization of a temperature-sensitive mutant of a ubiquitin-conjugating enzyme and its use as a heat-inducible degradation signal. Anal Biochem. 1999; 272(2):263-9. DOI: 10.1006/abio.1999.4190. View

3.
Jentsch S, Seufert W, Sommer T, Reins H . Ubiquitin-conjugating enzymes: novel regulators of eukaryotic cells. Trends Biochem Sci. 1990; 15(5):195-8. DOI: 10.1016/0968-0004(90)90161-4. View

4.
Bartel B, Wunning I, Varshavsky A . The recognition component of the N-end rule pathway. EMBO J. 1990; 9(10):3179-89. PMC: 552047. DOI: 10.1002/j.1460-2075.1990.tb07516.x. View

5.
Sung P, Berleth E, Pickart C, Prakash S, Prakash L . Yeast RAD6 encoded ubiquitin conjugating enzyme mediates protein degradation dependent on the N-end-recognizing E3 enzyme. EMBO J. 1991; 10(8):2187-93. PMC: 452907. DOI: 10.1002/j.1460-2075.1991.tb07754.x. View